Publisher
Springer Berlin Heidelberg
Reference71 articles.
1. Nesbit RM and Baum WC: Endocrine control of prostatic carcinoma. Clinical and statistical survey of 1,818 cases. JAMA 1950 (143):1317–1320
2. Robinson RMG, Shearer RJ, Fergusson JD: Adrenal suppression in the treatment of carcinoma of the prostate. Br J Urol 1974 (46):555
3. Stoliar B, Albert DJ: SCH 13521 in the treatment of advanced carcinoma of the prostate. J Urol 1974 (111):803
4. Sogani PC, Ray B, Whitmore WF Jr: Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment. Urology 1975 (6):164
5. Labrie F, Dupont A, Bélanger A, Giguère M, Borsanyi JP, Lacourcière Y, Emond J, Monfette G, Lachance R: The importance of combination therapy with Flutamide and castration (LHRH agonist or orchiectomy) in previously untreated as well as previously treated patients with advanced prostate cancer. In: JGM Klijn, R Paridaens, JA Foekens (eds) Hormonal Manipulation of Cancer: Peptides, Growth Factors and (Anti)-Steroidal Agents. Raven Press, New York 1986